About this trial
Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
This is a VAMC based Quality Improvement Partnered Evaluation Initiative. VA sites from around the country that agreed to participate are included.
Disqualifiers
N/A
Trial population
Participating VA Medical Centers
Trial design
Other
Other
Treatments tested in this trial
External Facilitation
Other interventionMulti-component facilitation strategy to address identified implementation needs
Treatment groups
Trial outcomes
Primary outcomes
Receipt of Combined Tobacco Dependence Treatment
Participation in counseling and pharmacotherapy within 90 days of lung cancer screening referral
Secondary outcomes
Number of Veterans Receiving ANY Tobacco Dependence Treatment Therapy
Participation in ANY tobacco dependence treatment therapy (including but not limited to pharmacotherapy or counseling) for eligible Veterans in lung cancer screening who smoke
Number of Veterans Receiving of Pharmacotherapy or Counseling Alone
Participation in individual treatment options among patients in lung cancer screening who smoke. These are defined as Pharmacotherapy (nicotine replacement, bupropion, varenicline, combination treatments) and counseling (individual or group tobacco visits delivered by any modality).
Cost Associated with Tobacco Dependence Treatment Among Lung Cancer Screening Participants who Smoke
Evaluate facility level costs and economic impacts of tobacco treatment for patients in lung cancer screening who smoke.
Rate of Short-term Cessation Among Veterans In Lung Cancer Screening who Smoke
Short-term cessation data among eligible Veterans in lung cancer screening who smoke as gathered by chart review
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
VA Office of Research and Development
Lead sponsor
VA Oncology and Precision Medicine
Collaborator
VA Tobacco Use Treatment National Program Office
Collaborator
VA National Center for Lung Cancer Screening
Collaborator
This trial is not recruiting at the moment. You can still explore other options: